Has Robert Forinash received payments from drug or device companies?

Yes. Drug and device makers reported $2,310 in general payments to Robert Forinash across 170 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Robert Forinash did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Robert Forinash come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Robert Forinash

General Practice · Gastonia, NCNPI 1639239254

Payments from drug & device makers

$2,310in general payments, 2019–2025

Across 170 payments — averaging $13.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

AbbVie$604
Johnson & Johnson$367
Alkermes, Inc.$231
Otsuka America Pharmaceutical, Inc.$205
Supernus Pharmaceuticals, Inc.$140
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$105
plus $656 from 21 others

What the payments were for

Food & beverage$2,26398%
Education$472%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
AbbVie(2 entities)	80	$604
Johnson & Johnson	13	$367
Alkermes, Inc.	5	$231
Otsuka America Pharmaceutical, Inc.	11	$205
Supernus Pharmaceuticals, Inc.	6	$140
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)	5	$105
Sunovion Pharmaceuticals Inc.	12	$68
Noven Therapeutics, LLC	5	$67
Indivior Inc.	3	$61
Gilead	4	$57
Teva Pharmaceuticals USA, Inc.	3	$49
Novo Nordisk	3	$40
Neurocrine Biosciences, Inc.	2	$34
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC	2	$30
Almatica Pharma LLC	2	$29
GSK	2	$28
Ironshore Pharmaceuticals Inc.	2	$25
Biohaven Pharmaceutical Holding Company Ltd.	1	$21
Takeda Pharmaceuticals U.S.A., Inc.	1	$21
Rhodes Pharmaceuticals L.p.	1	$20
Philips North America LLC	1	$20
Shire North American Group Inc	1	$19
Vanda Pharmaceuticals Inc.	1	$18
Neuronetics, Inc.	1	$14
Eisai Inc.	1	$13
Neos Therapeutics, LP	1	$12
Merck	1	$11

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

SPRAVATO$108
VRAYLAR$106

How this compares

$2,310 in reported general payments places this provider in the 90th percentile of 2,924 general practice providers in North Carolina.

See all general practice providers in North Carolina →

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Zolpidem Tartrate	12	$64

Paid to pharmacies, not to this prescriber.

Other general practice in Gastonia

Thad JohnstonGastonia$41K
Matthew MillerCharlotte$937K
James BarberDurham$768K
Robert LoweCharlotte$615K
Howard JamesSanford$483K
Clifton CameronFayetteville$404K
Michael HarrisonRaleigh$249K
Ronnie DavidsonMooresville$151K
Leo HaydtHolly Springs$119K
Andrew KellyGreensboro$115K

See the full list for North Carolina →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →